Meeting Overview - The second extraordinary general meeting of shareholders was held on August 19, 2025, at a designated location in Beijing [2] - The meeting was convened by the board of directors and chaired by Chairman Liu Yuetao, utilizing both on-site and online voting methods [2] Attendance - All 7 serving directors attended the meeting, including 4 independent directors [3] - All 3 serving supervisors were present, along with the board secretary and other senior executives [3] Resolutions Passed - The proposal to abolish the supervisory board and amend the Articles of Association was approved [4] - The following governance rules were revised and approved: - Shareholders' Meeting Rules [4] - Board of Directors' Meeting Rules [4] - External Guarantee Management Measures [4] - Related Party Transaction Management Measures [4] - Fundraising Management Measures [4] - Independent Directors' Work System [4] - The proposal to abolish the Supervisory Meeting Rules was also approved [4] Voting Results - Proposals 1, 2.01, 2.02, and 3 were special resolutions, requiring more than two-thirds of the voting rights held by attending shareholders to pass [4] - Proposals 2.03 to 2.06 were also successfully passed [4] Legal Verification - The meeting was witnessed by Beijing Guofeng Law Firm, with lawyers confirming the legality of the meeting's procedures and resolutions [5] - The legal opinion was signed and stamped by the law firm's principal [5]
国药集团药业股份有限公司2025年第二次临时股东大会决议公告